HomeGLS • NSE
add
Glenmark Life Sciences Ltd
Previous close
₹1,151.65
Day range
₹1,110.00 - ₹1,171.00
Year range
₹611.20 - ₹1,335.10
Market cap
138.76B INR
Avg Volume
392.35K
P/E ratio
31.10
Dividend yield
1.99%
Primary exchange
NSE
Market news
.INX
0.00%
1.86%
Financials
Income Statement
Revenue
Net income
(INR) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 5.89B | 1.76% |
Operating expense | 1.56B | 3.91% |
Net income | 1.11B | -17.69% |
Net profit margin | 18.94 | -19.13% |
Earnings per share | 9.08 | -17.83% |
EBITDA | 1.58B | -17.07% |
Effective tax rate | 25.80% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.02B | -2.52% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 23.32B | — |
Shares outstanding | 122.51M | — |
Price to book | 6.05 | — |
Return on assets | — | — |
Return on capital | 15.44% | — |
Cash Flow
Net change in cash
(INR) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 1.11B | -17.69% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2011
Website
Employees
2,014